FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Uta Schmidt

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Physiology

Gene Expression Regulation, Neoplastic

Procedures

Reverse Transcriptase Polymerase Chain Reaction

Co-author Network

Publications

TOP 3
Uta Schmidt; Susanne Fuessel; Rainer Koch; Gustavo B Baretton; Andrea Lohse; Silke Tomasetti; Susanne Unversucht; Michael Froehner; Manfred P Wirth; Axel Meye
Quantitative multi-gene expression profiling of primary prostate cancer.
Kai Kraemer; Uta Schmidt; Susanne Fuessel; Alexander Herr; Manfred P Wirth; Axel Meye
Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR.
Doreen Kunze; Susanne Fuessel; Axel Meye; Manfred P Wirth; Uta Schmidt
Functional analyses of C13orf19/P38IP in prostate cell lines.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Uta Schmidt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Uta Schmidt; Susanne Fuessel; Rainer Koch; Gustavo B Baretton; Andrea Lohse; Silke Tomasetti; Susanne Unversucht; Michael Froehner; Manfred P Wirth; Axel Meye
Quantitative multi-gene expression profiling of primary prostate cancer.
The Prostate 2006;66(14):1521-34.
2006: Kai Kraemer; Uta Schmidt; Susanne Fuessel; Alexander Herr; Manfred P Wirth; Axel Meye
Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR.
International journal of cancer. Journal international du cancer 2006;119(6):1276-84.
2006: Doreen Kunze; Susanne Fuessel; Axel Meye; Manfred P Wirth; Uta Schmidt
Functional analyses of C13orf19/P38IP in prostate cell lines.
Oncology reports 2006;15(6):1599-604.
2006: Susanne Fuessel; Bernd Weigle; Uta Schmidt; Gustavo B Baretton; Rainer Koch; Michael Bachmann; E Peter Rieber; Manfred P Wirth; Axel Meye
Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairs.
Cancer letters 2006;236(1):95-104.
2006: Susanne Fuessel; Jana Herrmann; Shuangli Ning; Matthias Kotzsch; Kai Kraemer; Uta Schmidt; Oliver W Hakenberg; Manfred P Wirth; Axel Meye
Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
Cancer letters 2006;232(2):243-54.
2006: Michael Froehner; Oliver W Hakenberg; Rainer Koch; Uta Schmidt; Axel Meye; Manfred P Wirth
Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer.
Urologia internationalis 2006;76(1):27-30.
2005: Karen Blümke; Udo Bilkenroth; Uta Schmidt; Andres M Melchior; Susanne Füssel; Frank Bartel; Hans Heynemann; Paolo Fornara; Helge Taubert; Manfred P Wirth; Axel Meye
Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study.
Oncology reports 2005;14(4):895-9.
2005: Uta Schmidt; Susanne Fuessel; Michael Haase; Kai Kraemer; Axel Meye; Manfred P Wirth
Quantification of C13orf19/P38IP mRNA expression by quantitative real-time PCR in patients with urological malignancies.
Cancer letters 2005;225(2):253-60.
2005: Sabine Krause; Yvonne Förster; Kai Kraemer; Susanne Fuessel; Matthias Kotzsch; Uta Schmidt; Manfred P Wirth; Axel Meye; Bernd Schwenzer
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and Cisplatin.
The Journal of urology 2005;174(1):328-31.
2004: Kai Kraemer; Susanne Fuessel; Matthias Kotzsch; Shuangli Ning; Uta Schmidt; Manfred P Wirth; Axel Meye
Chemosensitization of bladder cancer cell lines by human telomerase reverse transcriptase antisense treatment.
The Journal of urology 2004;172(5 Pt 1):2023-8.
2004: Shuangli Ning; Susanne Fuessel; Matthias Kotzsch; Kai Kraemer; Matthias Kappler; Uta Schmidt; Helge Taubert; Manfred P Wirth; Axel Meye
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.
International journal of oncology 2004;25(4):1065-71.
2004: Christian Hoefling; Hannelore Schmidt; Matthias Meinhardt; Andrea Lohse; Helge Taubert; Susanne Fuessel; Uta Schmidt; Katja Schuster; Gustavo B Baretton; Manfred P Wirth; Axel Meye
Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma.
International journal of molecular medicine 2004;13(6):835-42.
2004: Uta Schmidt; Udo Bilkenroth; Clemens Linné; Susanne Fuessel; Kai Kraemer; Michael Froehner; Manfred P Wirth; Axel Meye
Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapy.
International journal of oncology 2004;24(6):1393-9.
2004: Susanne Fuessel; Bernd Kueppers; Shuangli Ning; Matthias Kotzsch; Kai Kraemer; Uta Schmidt; Axel Meye; Manfred P Wirth
Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cells.
The Journal of urology 2004;171(6 Pt 1):2471-6.
2003: Kai Kraemer; Susanne Fuessel; Uta Schmidt; Matthias Kotzsch; Bernd Schwenzer; Manfred P Wirth; Axel Meye
Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3794-800.
2003: Susanne Fuessel; Denise Sickert; Axel Meye; Ulrich Klenk; Uta Schmidt; Marc Schmitz; Anne-Katrin Rost; Bernd Weigle; Andrea Kiessling; Manfred P Wirth
Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
International journal of oncology 2003;23(1):221-8.
2003: Matthias Kappler; Matthias Kotzsch; Frank Bartel; Susanne Füssel; Christine Lautenschläger; Uta Schmidt; Peter Würl; Matthias Bache; Hannelore Schmidt; Helge Taubert; Axel Meye
Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):1098-104.
2002: Axel Meye; Udo Bilkenroth; Uta Schmidt; Susanne Füssel; Katja Robel; Andres M Melchior; Karen Blümke; Diana Pinkert; Frank Bartel; Clemens Linne; Helge Taubert; Manfred P Wirth
Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
International journal of oncology 2002;21(3):521-30.
2001: U Fiedler; W Ehlers; Axel Meye; Susanne Füssel; G Faller; Uta Schmidt; Manfred P Wirth
LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
Anticancer research 2001;21(4A):2341-50.
2001: A Schindler; U Fiedler; Axel Meye; Uta Schmidt; Susanne Füssel; Christian Pilarsky; J Herrmann; Manfred P Wirth
Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro.
International journal of oncology 2001;19(1):25-30.
2001: Uta Schmidt; U Fiedler; Christian Pilarsky; W Ehlers; Susanne Füssel; Michael Haase; G Faller; G Sauter; Manfred P Wirth
Identification of a novel gene on chromosome 13 between BRCA-2 and RB-1.
The Prostate 2001;47(2):91-101.
1998: Christian Pilarsky; Uta Schmidt; C Eissrich; J Stade; SE Froschermaier; Michael Haase; G Faller; T W Kirchner; Manfred P Wirth
Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer.
The Prostate 1998;36(2):85-91.